Oncological results in the prospective study showed that a modulating effect on PSA seemed to influence clinical practice and the number of PCa-related investigations, and that prescribing a fermented soy supplement in patients at increased risk of PCa could lead to a better selection of patients at real increased risk of having occult PCa. Here, KLK3 is linked to posterior cortical atrophy.